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Objective: To describe cross-sectional associations between mass effect or signal intensity alteration of
the suprapatellar fat pad (SPFP) with knee symptoms and structure in older adults.
Methods: A cross-sectional sample of 904 randomly selected subjects (mean 62.4 years, 49.9% female)
was studied. T1- or T2-weighted fat suppressed magnetic resonance imaging (MRI) was used to assess
mass effect or signal intensity alteration of SPFP, cartilage volume, cartilage defects, and bone marrow
lesions (BMLs). Knee pain was assessed by self-administered Western Ontario McMaster Osteoarthritis
Index (WOMAC) questionnaire. The Osteoarthritis Research Society International (OARSI) atlas was used
to assess knee osteophyte, joint space narrowing (JSN) and radiographic osteoarthritis (ROA). Univariable
and multivariable linear or logistic regression analyses were used to examine the associations.
Results: After adjustment for confounders including age, sex, body mass index (BMI), disease status,
tibial bone area and/or ROA, the presence of SPFP mass effect was signiﬁcantly associated with any knee
pain (OR: 2.39; 95% conﬁdence interval (CI): 1.54, 3.70) and ROA (OR: 2.10; 95% CI: 1.33, 3.31) but not
with cartilage volume, cartilage defects or BMLs. The presence of SPFP signal intensity alteration was
signiﬁcantly associated with any knee pain (OR: 1.90; 95% CI: 1.43, 2.53), ROA (OR: 1.83; 95% CI: 1.37,
2.45), any BMLs (OR: 1.55; 95% CI: 1.17, 2.06) but not with cartilage volume and cartilage defects. Sig-
niﬁcant associations with knee pain and BMLs were more evident in subjects with ROA. Presence of SPFP
mass effect and/or signal intensity alteration combined was associated with any tibial cartilage defects
(OR: 1.45; 95% CI: 1.04, 2.04).
Conclusions: SPFP mass effect and/or signal intensity alterations are deleteriously associated with knee
pain, radiographic OA and BMLs in this cross-sectional study, suggesting that SPFP abnormalities may
contribute to pain and structural abnormalities in the knee.
© 2014 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.3Introduction
Globally approximately 250 million people have osteoarthritis
(OA) of the knee (3.6% of the population)1. Themain symptom of OA
is joint pain, causing loss of function. It is a common cause of
chronic disability in older adults2. OA involves the entire joint or-
gan, including articular cartilage, subchondral bone, menisci,o: C. Ding, Private Bag 23,
; Fax: 61-3-62267704.
ng).
ternational. Published by Elsevier Lligaments, periarticular muscle, capsule, and synovium . The
pathogenesis of knee OA is not fully understood, but both me-
chanical and metabolic factors are believed to play important roles.
In addition, age4, female sex5, and bodymass index (BMI)6 arewell-
known risk factors for knee OA.
Three distinct fat-pads are located in the anterior knee
compartment: suprapatellar (SPFP) or quadriceps fat pad, prefe-
moral or supratrochlear fat pad, and infrapatellar or Hoffa fat pad.
Each is interposed between joint capsule externally and synovium-
lined joint cavity and its extensions internally7e10. A normal SPFP
lies on the patellar base and is rather triangular. It ﬁlls the gaptd. All rights reserved.
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the superior aspect of patellar cartilage, increasing the congruency
of the extensor mechanism. Posteriorly, the suprapatellar joint
recess, an upward extension of the knee joint cavity, separates SPFP
from prefemoral fat pad.
Several studies described the associations between anteriorknee
pain and SPFP mass effect (deﬁned as a posterior convex border) or
signal intensity alteration assessed byMRI but reported inconsistent
results10e12possiblydue tovariations in factors suchas studydesign,
study populations and sample size. So far, there are few studies
reporting the association between SPFP and knee OA measures, so
the role of SPFP in knee symptoms and structure is largely unknown.
The aim of this study was, therefore, to describe the associations
between SPFP mass effect or signal intensity alteration and knee
symptoms or structural abnormalities in older adults.
Materials and methods
Subjects
This study was a part of the Tasmanian Older Adult Cohort
(TASOAC) study, an ongoing prospective, population-based study
aimed at identifying the environmental, genetic, and biochemical
factors associated with the development and progression of OA
(assessed by both X-ray and MRI). Subjects (n ¼ 1,100) between the
age of 50 and 79 years were randomly selected from the roll of
electors in southern Tasmania (population 229,000), a compre-
hensive population listing with an equal number of men and
women. The overall response rate was 57%. Institutionalized per-
sons and subjects with contraindications to MRI were excluded
(n ¼ 196). The study was approved by the Southern Tasmanian
Health and Medical Human Research Ethics Committee, and writ-
ten informed consent was obtained from all participants. Self-
report of diseases including cardiovascular disease, diabetes, and
rheumatoid arthritis was recorded by questionnaire.
Anthropometrics assessment
Height was measured to the nearest 0.1 cm (with shoes, socks,
and headgear removed) using a stadiometer. Weight was measured
to the nearest 0.1 kg (with shoes, socks, and bulky clothing
removed) by using a single pair of electronic scales (Delta Model
707, Seca, Hamburg, Germany) that were calibrated using a known
weight at the beginning of each clinic. BMI (weight (kg)/height
(m2)) was also calculated.
Knee pain assessment
The assessment of knee pain (walking on ﬂat surface, going up/
down stairs, at night, sitting/lying, and standing upright) was made
by self-administered, using the Western Ontario McMaster Osteo-
arthritis Index (WOMAC) with a 10-point scale from 0 (no pain,
stiffness, or function problems) to 9 (most severe)13. Each
compartment of joint pain was summed to create a total pain
(0e45), and the presence of knee pain was deﬁned as a total score
or a subscale score of 114,15.
Knee radiographic assessment
A standing anteroposterior semi-ﬂexed view of the right knee
with 15 of ﬁxed knee ﬂexion was performed in all subjects, and
radiographs were individually assessed for joint space narrowing
(JSN) and osteophytes on a scale of 0e3 (0 ¼ normal and 3 ¼ most
severe) by using the Osteoarthritis Research Society International
(OARSI) atlas developed by Altman et al.16. The osteophytes and JSNscores were summed as the knee total radiographic OA (ROA) score,
and grade of 1 or greater was used to deﬁne the presence of knee
ROA, JSN or osteophytes, as previously described17.
Magnetic resonance imaging (MRI) assessment
MRI scans of the right knees were performed at baseline. Knees
were imaged in the sagittal plane on a 1.5-T whole body magnetic
resonance unit (Picker, Cleveland, OH) with use of a commercial
transmit-receive extremity coil. The following image sequences
were used: (1) a T1-weighted fat saturation 3D gradient recall
acquisition in the steady state; ﬂip angle 55; repetition time
58 ms; echo time 12 ms; ﬁeld of view 16 cm; 60 partitions;
512  512 matrix; acquisition time 11 min 56 s; one acquisition.
Sagittal images were obtained at a partition thickness of 1.5 mm
and an in-plane resolution of 0.31  0.31 (512  512 pixels). (2) a
T2-weighted fat suppressed fast spin echo, ﬂip angle 90, repetition
time 3,067 ms, echo time 112 ms, ﬁeld of view 16 cm, 15 partitions,
228  256-pixel matrix; sagittal images were obtained at a slice
thickness of 4 mm with an interslice gap of 0.5e1.0 mm.
The areas of SPFP were measured by manually drawing disar-
ticulation contours around the SPFP boundaries on a section-by-
section T2-weighted MR image, using the software program
Osiris (University of Geneva). The maximum area was selected to
represent the SPFP area. The presence of mass effect on the
suprapatellar recess was assessed as evident by convex posterior
contour in at least two continuous slices on T2-weighted MR im-
ages10 [Fig. 1]. SPFP signal intensity alterations on T2-weighted MR
images were recorded if hyperintense signal changes were
observed within SPFP11 [Fig. 1]. One observer graded the SPFP area,
mass effect and signal intensity alteration. Intraobserver reliability
was assessed in 30 subjects with a coefﬁcient of variation (CV) of 4%
for SPFP area, and a kappa of 0.87 and 0.81 for mass effect and
signal intensity alteration, respectively.
Knee cartilage volume was determined on the T1-weighted MR
images with image processing on an independent workstation, as
previously described18,19. Total knee cartilage volume was divided
into patellar, medial and lateral tibial cartilage volume by manually
drawing disarticulation contours around the cartilage boundaries,
section by section, which were then resampled for the ﬁnal 3-
dimensional rendering18. The CVs for this method in our hands
was 2.1e2.6%18.
Knee cartilage defects (0e4 scale) were determined at medial
tibial, medial femoral, lateral tibial, lateral femoral, and patellar
sites as previously described20,21 as follows: grade 0 ¼ normal
cartilage; grade 1 ¼ focal blistering and intracartilaginous low-
signal intensity area with an intact surface; grade
2 ¼ irregularities on the surface or bottom and loss of thickness
<50%; grade 3¼ deep ulcerationwith loss of thickness >50%; grade
4 ¼ full-thickness chondral wear with exposure of subchondral
bone. The presence of cartilage defect was deﬁned as a cartilage
defect score of 2 at one site. Intraobserver reliabilities were
0.89e0.94 and interobserve reliabilities were 0.85e0.9320.
Subchondral bone marrow lesions (BMLs) were deﬁned as
discrete areas of increased signal adjacent to the subcortical at any
compartment of femur and/or tibial on the T2-weighted MR image,
and the intraobserver reliabilities were 0.89e1.00, as previously
described22. Tibial plateau bone area was determined by manually
measuring on axial T1-weighted MR images, as previously
described17.
Data analysis
Two-tailed Student's t-tests or c2 tests were used to compare
differences in means or proportions, as appropriate, between those
Fig. 1. Suprapatellar fat-pad (SPFP) on T2-weighted MR images. (a) Normal SPFP (without mass effect and signal alteration) (arrowhead); (b) SPFP with mass effect (arrowhead); (c)
SPFP with signal intensity alteration (arrowhead); (d) SPFP with both mass effect and signal intensity alteration (arrowhead).
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variable and multivariable linear regression analyses were used to
examine the associations between cartilage volume and mass ef-
fect/signal intensity alteration before and after adjustment for age,
sex, BMI, disease status (rheumatoid arthritis, diabetes, cardiovas-
cular diseases), tibial bone area and ROA. Univariable and multi-
variable binary logistic regression analyses were used to examine
the associations between categorical outcomes (e.g., ROA, BML,
knee pain) andmass effect/signal intensity alteration before or after
adjustment for the same covariates (except for tibial bone area).
Interactions between ROA and SPFP measures on outcome mea-
sures (knee pain, BMLs, cartilage volume, and cartilage defects)
were investigated by regressing an individual outcome on a binary
(0/1) term for ROAwithin an SPFP measure, and assessed by testing
the statistical signiﬁcance of the coefﬁcient of a (ROA  SPFP
measure). We also separated subjects with and without ROA for
analyses.
A P-value <0.05 (2-tailed) or a 95% conﬁdence interval (CI) not
including the null point (for linear regression) or 1 (for logistic
regression) was considered as statistical signiﬁcance. All statistical
analyses were performed on SPSS version 20.0 for Windows (SPSS
Inc., Chicago, IL).
Results
A total of 904 subjects (50% female) with average age of 62.4
years (range, 50e79 years) participated in the present study. There
were no signiﬁcant differences in demographic factors (age, sex,
and BMI) between these participants and those excluded from this
study (n ¼ 196) (data not shown). SPFP mass effect on the supra-
patellar recess was observed in 13% (118/904) of the participants.
Signal intensity alteration was observed in 42% (379/904) of theparticipants, and was modestly but statistically signiﬁcantly asso-
ciated with SPFP mass effect (r ¼ 0.19, P < 0.001).
Characteristics of the participants are presented in Table I.
Compared with those without SPFP mass effect and signal intensity
alteration, subjects with SPFP mass effect or signal intensity alter-
ation had statistically signiﬁcantly greater SPFP size, and higher
percentages of ROA, medial and lateral JSN, prevalent BMLs, medial
tibiofemoral (MTF) osteophytes and lateral TF cartilage defects. In
addition, subjects with SPFP mass effect or signal intensity alter-
ation tended to be older, and have higher BMI, less tibial and
patellar cartilage volume, higher percentages of lateral TF osteo-
phytes and higher medial TFMTF and patellar cartilage defects,
although these were not statistically signiﬁcant.
In univariable analyses, SPFP mass effect was statistically
signiﬁcantly associated with the presence of total WOMAC knee
pain, pain on ﬂat surface, pain on stairs, pain in bed, and painwhen
standing, with a borderline signiﬁcance for pain when sitting
(P ¼ 0.062) [Fig. 2(a)]; SPFP signal intensity alteration was statis-
tically signiﬁcantly associated with the presence of total WOMAC
knee pain, pain on stairs, pain in bed, pain when sitting and pain
when standing, but not with knee pain when walking on ﬂat sur-
face [Fig. 2(b)]. After adjustment for covariates as listed in Table II,
the associations between SPFP mass effect and most knee pain
measures (except pain when standing) remained statistically sig-
niﬁcant, and the associations between SPFP signal intensity alter-
ation and total WOMAC knee pain, pain on stairs, and pain when
standing remained statistically signiﬁcant. Furthermore, SPFP mass
effect and signal intensity alteration had a small additive effect on
knee pain (prevalence of any total knee pain: 43% in those without
SPFP alterations, 59% in those with any alteration, and 61% in those
with both). Themagnitude of associations with knee pain remained
unchanged after further adjustment for total BMLs (data not
Table I
Characteristics of participants based on SPFP mass effect and signal intensity alteration
Total sample n ¼ 904 Without mass effect and
signal alterations n ¼ 485
With mass effect or signal alteration n ¼ 419 P-value
Age (year) 62.4 (7.4) 62.1 (7.4) 62.7(7.4) 0.286
Female sex (%) 49.9 49.1 50.8 0.597
Body mass index (kg/m2) 27.7 (4.6) 27.5 (4.8) 27.9 (4.4) 0.117
Medial tibial cartilage volume (ml) 2.3 (0.6) 2.3 (0.6) 2.2 (0.6) 0.092
Lateral tibial cartilage volume (ml) 2.8 (0.7) 2.8 (0.7) 2.7 (0.7) 0.778
Patella cartilage volume (ml) 3.2 (0.9) 3.3 (0.9) 3.2 (1.0) 0.336
Medial tibial bone area (cm2) 20.9 (3.1) 20.9 (3.0) 21.0 (3.1) 0.887
Lateral tibial bone area (cm2) 12.2 (2.2) 12.2 (2.2) 12.2 (2.2) 0.982
SPFP size (mm2) 67.8 (22.9) 62.4 (20.2) 74.1 (24.2) <0.001
ROA (%) 59.4 51.7 68.4 <0.001
Medial JSN (%) 53.2 46.6 60.8 <0.001
Lateral JSN (%) 24.1 20.4 28.4 0.007
MTF osteophytes (%) 7.3 5.5 9.4 0.033
LTF osteophytes (%) 4.0 3.5 4.6 0.456
BML present (%) 43.8 39.2 49.2 0.003
MTF cartilage defects (%) 24.1 23.3 25.1 0.537
LTF cartilage defects (%) 22.3 19.2 25.8 0.016
Patellar cartilage defects (%) 40.4 39.4 41.5 0.512
Total WOMAC knee pain (%) 51.4 43.0 61.2 <0.001
Two-tailed t tests were used for differences between means; c2 tests were used for proportions (percentages). Signiﬁcant differences are shown in bold.
Mean (SD) except for percentages.LTF: lateral tibiofemoral.
a
b
Fig. 2. Associations between mass effect and signal intensity alteration of SPFP and
knee pain in unadjusted analyses. (a) SPFP mass effect was signiﬁcantly associated
with total WOMAC knee pain, pain on ﬂat surface, pain on stairs, pain in bed, pain
when standing; (b) SPFP signal intensity alteration was signiﬁcantly associated to total
WOMAC knee pain, pain on stairs, pain in bed, pain when sitting and pain when
standing.
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SPFP measures on knee pain measures (data not shown); however,
the signiﬁcant associations were noticed mainly in subjects with
ROA (Table II).
In univariable analyses, SPFP mass effect was statistically
signiﬁcantly associated with JSN and osteophytes [Fig. 3(a)], and
SPFP signal intensity alteration was statistically signiﬁcantly asso-
ciated with JSN but not with osteophytes in the medial TF
compartment [Fig. 3(b)]. These signiﬁcant associations remained
unchanged after adjustment for covariates (Table III). SPFP mass
effect and signal intensity alteration were also statistically signiﬁ-
cantly associated with prevalence of ROA in adjusted analyses
(Table III). SPFP mass effect, not signal intensity alteration, was
signiﬁcantly associated with osteophytes in lateral TF compart-
ment; whereas SPFP mass effect and signal intensity alteration
were not signiﬁcantly associated with JSN in lateral TF compart-
ment (Table III). Moreover, SPFP mass effect and signal intensity
alteration had an additive effect on ROA (prevalence of ROA: 52% in
those without SPFP alteration, 67% in those with any alteration, and
76% in those with both alterations). The magnitude of associations
with knee radiographic changes remained unchanged after further
adjustment for total BMLs (data not shown).
We did not ﬁnd statistically signiﬁcant associations between
SPFP mass effect or signal intensity alteration (considered indi-
vidually) and knee cartilage volume or cartilage defects in uni-
variable and multivariable analyses (data not shown). However,
presence of any/both SPFP alterations was statistically signiﬁcantly
associated with any tibial (medial and lateral combined) cartilage
defects inmultivariable analysis (OR: 1.47; 95% CI: 1.05, 2.05). There
was no signiﬁcant interaction between ROA and SPFP alterations on
tibial cartilage defects (P ¼ 0.849).
SPFP mass effect was not associated with BMLs at any TF com-
partments in univariable (data not shown) and multivariable ana-
lyses (Table IV). In contrast, SPFP signal intensity alteration was
statistically signiﬁcantly and positively associated with prevalence
of lateral TF BMLs, any BMLs in the TF compartment and BML total
score after adjustment for covariates (Table IV). SPFP signal in-
tensity alteration was not signiﬁcantly associated with BMLs in
medial TF compartment (Table IV). There were no signiﬁcant in-
teractions between ROA and SPFP measures on BMLs (except for
that between ROA and SPFP mass effect on any BMLs at TFcompartment, P ¼ 0.013), but the signiﬁcant associations were
observed in subjects with ROA, not in those without ROA (Table IV).
The above signiﬁcant associations for SPFP mass effect or signal
intensity alteration remained unchanged after further adjustment
for each other (data not shown).
Table II
Associations between SPFP mass effect, signal intensity alteration andWOMAC keen
pain
SPFP mass effect
multivariable*
OR (95% CI)
SPFP signal alteration
multivariable*
OR (95% CI)
Total sample
Total WOMAC knee pain 2.38 (1.54, 3.69) 1.90 (1.42, 2.53)
Pain on ﬂat surface 1.59 (1.03, 2.45) 1.09 (0.79, 1.51)
Pain on stairs 1.81 (1.20, 2.75) 1.69 (1.27, 2.25)
Pain in bed 1.76 (1.16, 2.69) 1.27 (0.93, 1.73)
Pain when sitting 1.43 (0.92, 2.22) 1.24 (0.90, 1.71)
Pain when standing 1.53 (0.98, 2.36) 1.47 (1.06, 2.02)
Without ROA
Total WOMAC knee pain 1.39 (0.63, 3.03) 1.82 (1.15, 2.90)
Pain on ﬂat surface 1.77 (0.76, 4.15) 1.22 (0.71, 2.11)
Pain on stairs 1.39 (0.64, 3.04) 1.47 (0.93, 2.32)
Pain in bed 1.29 (0.53, 3.11) 1.42 (0.84, 2.41)
Pain when sitting 1.04 (0.39, 2.79) 1.25 (0.71, 2.20)
Pain when standing 2.16 (0.94, 4.95) 1.50 (0.88, 2.56)
With ROA
Total WOMAC knee pain 3.08 (1.79, 5.30) 1.95 (1.35, 2.81)
Pain on ﬂat surface 1.55 (0.93, 2.59) 1.03 (0.69, 1.53)
Pain on stairs 2.06 (1.25, 3.36) 1.84 (1.28, 2.65)
Pain in bed 1.76 (1.16, 2.69) 1.20 (0.82, 1.76)
Pain when sitting 1.59 (0.96, 2.64) 1.24 (0.83, 1.83)
Pain when standing 1.37 (0.81, 2.30) 1.45 (0.97, 2.17)
Dependent variables: knee pain (yes vs no). Independent variables: SPFP mass ef-
fects or signal intensity alteration (yes vs no).
Signiﬁcant differences are shown in bold.
* Adjusted for age, sex, BMI, diabetes, cardiovascular diseases, rheumatoid
arthritis and/or ROA.
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To the best of our knowledge, this is the ﬁrst study to describe
the associations between mass effect on the suprapatellar jointa
b
Fig. 3. Associations between mass effect and signal intensity alteration of SPFP and
knee radiographic changes in unadjusted analyses. (a) Mass effect was signiﬁcantly
associated with both JSN and osteophytes; (b) Signal intensity alteration was signiﬁ-
cantly associated with JSN but not signiﬁcantly associated with osteophytes.recess or signal intensity alteration of SPFP and clinical and struc-
tural abnormalities of knee joint in a large sample of older people.
We found that SPFP mass effect and signal intensity alterationwere
positively associated with knee pain, ROA and JSN at medial TF
compartment. They had independent and additive effects on knee
pain and ROA. While SPFP mass effect was positively associated
with osteophytes, SPFP signal intensity alteration was associated
with increased BMLs. The signiﬁcant associations with knee pain
and BMLs were more evident in subjects with ROA. Although SPFP
mass effect was not associated some knee pain subscales (when
sitting and standing), lateral TF JSN, BMLs, cartilage defects and
cartilage volume, and SPFP signal intensity alteration was not
associated some knee pain subscales (walking on ﬂat surface, when
in bed and sitting), lateral TF JSN, osteophytes, medial TF BMLs,
cartilage defects and cartilage volume, our results suggest that SPFP
may be involved in the pathological process of knee OA which
needs to be conﬁrmed by future longitudinal studies.
MR imaging is the most accurate non-invasive tool for assess-
ment of the knee23. The convex from the posterior border can be
used as an effective criterion for assessment of SPFP mass effect10.
In this study, we used this criterion to discriminate SPFPmass effect
and found that its prevalence was 13% in older adults which is
comparable with the prevalence of 12% reported by Roth et al.10 and
13.8% by Tsavalas et al.12. We also assessed the SPFP signal intensity
alteration using the criterion from Shashin et al.11 and found that its
prevalence was 42%, and it signiﬁcantly correlated withmass effect,
which is consistent with previous reports10e12. We also found sig-
niﬁcant associations between SPFP mass effect/signal intensity
alteration and major outcome measures, suggesting the assess-
ments of SPFP mass effect or signal intensity alteration can be valid.
The histological changes for SPFP mass effect or signal intensity
alteration are unclear, and they may be similar to the histological
changes described in infrapatellar fat pad which are characterized
by inﬂammation, swelling, hypertrophy, and ﬁbrosis and/or
calciﬁcation24e28.
Currently, cytokines and adipokines produced by inﬂammatory
cells and adipocytes have been regarded to play roles in the disease
progression of OA29. With signiﬁcant inﬁltration of immune cells,
adipose tissue in the knee joint can secrete cytokines, adipokines
and growth factors30, and thus has been considered as a risk factor
for the development of OA. Several in vitro and animal studies have
reported that infrapatellar fat pad can produce inﬂammatory cy-
tokines and adipokines which may have detrimental effects on
cartilage in knee OA31e33. SPFP may have similar properties; how-
ever, there is no clinical or epidemiological evidence to show if SPFP
has a role to play in knee OA.
Chronic knee pain is a hallmark of knee OA and some joint
structural abnormalities such as BMLs, osteophytes, meniscal tears,
synovitis and cartilage defects may be sources of knee pain34e36.
Because local fat pads are highly innervated37, they can be
responsible for knee pain. Roth et al.10 reported that SPFP mass
effect (not signal intensity alteration) was associated with anterior
knee pain in 92 consecutive knee MRI examinations from 84 pa-
tients, and Shabshin et al.11 suggested that SPFP mass effect might
be a cause of anterior knee pain. In contrast, Tsavalas et al.12 re-
ported that SPFP mass effect was not signiﬁcantly associated with
anterior knee pain. We chose the WOMAC scale to assess knee pain
which is separated as pain when walking on ﬂat surface, when
going up/down stairs, at night, when sitting/lying, and when
standing upright in this study. We found that SPFP mass effect and
signal intensity alteration were signiﬁcantly and independently
associated with total knee pain particularly in subjects with ROA.
Those with both SPFP mass effect and signal intensity alteration
had more knee pain. SPFP mass effect had signiﬁcant associations
with bothweight-bearing and non-weight bearing knee pain, while
Table III
Association between SPFP mass effect, signal intensity alteration and radiographic
osteoarthritis, JSN and osteophytes
SPFP mass effect
multivariable*
OR (95% CI)
SPFP signal
alteration
multivariable*
OR (95% CI)
Radiographic
osteoarthritis
2.10 (1.33, 3.31) 1.83 (1.37, 2.45)
MTF JSN 1.94 (1.26, 2.97) 1.62 (1.22, 2.15)
LTF JSN 1.52 (0.98, 2.35) 1.35 (0.98, 1.86)
MTF osteophytes 2.00 (1.03, 3.86) 1.68 (0.97, 2.91)
LTF osteophytes 2.35 (1.05, 5.23) 1.30 (0.64, 2.63)
Dependent variables: radiographic features (yes vs no). Independent variables: SPFP
mass effects or signal intensity alteration (yes vs no).
LTF: lateral tibiofemoral.
Signiﬁcant differences are shown in bold.
* Adjusted for age, sex, BMI, diabetes, cardiovascular diseases, and rheumatoid
arthritis.
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bearing but not non-weight bearing knee pain. The reasons un-
derlying these ﬁndings are unknown but the former has both
mechanical and inﬂammatory components while the latter is more
mechanical. Roth et al.10 suggested that knee pain could be
explained by impingement caused by an enlarged and edematous
SPFP.
Two preliminary studies failed to ﬁnd signiﬁcant associations
between SPFP and radiographic or structural changes of OA.
Shabshin et al.11 reported that SPFP mass effect was not associated
with patellofemoral cartilage abnormalities and did not report its
associations with ROA. Tsavalas et al.12 reported that SPFP mass
effect was not associated with patellofemoral joint ROA but its as-
sociation with TF ROA was not revealed. In the current study, SPFP
mass effect and signal intensity alteration were positively associ-
ated with TF ROA and these were largely contributed from the as-
sociations with JSN in the MTF compartment. JSN is a surrogate of
cartilage loss at a later stage of OA while MRI-assessed cartilage
defects and/or volume measure disease status at earlier stages of
OA38. We found signiﬁcant associations of SPFP mass effect andTable IV
Associations between SPFP mass effect, signal intensity alteration and BMLs
TF BMLs SPFP mass effect
multivariable*
SPFP signal alteration
multivariable*
OR (95% CI) OR (95% CI)
Total sample
Medial 0.95 (0.58, 1.56) 1.29 (0.92, 1.82)
Lateral 1.04 (0.63, 1.74) 1.56 (1.09, 2.23)
Any BMLs 0.90 (0.60, 1.35) 1.55 (1.17, 2.06)
Without ROA
Medial 1.19 (0.45, 3.15) 1.36 (0.77, 2.42)
Lateral 1.00 (0.36, 2.79) 1.30 (0.71, 2.37)
Any BMLs 0.90 (0.41, 1.98) 0.98 (0.62, 1.56)
With ROA
Medial 0.92 (0.52, 1.64) 1.28 (0.84, 1.96)
Lateral 1.08 (0.60, 1.96) 1.77 (1.11, 2.80)
Any BMLs 0.91 (0.56, 1.47) 2.06 (1.43, 2.96)
BMLs total score
(cm2/per grade)
b (95% CI) b (95% CI)
Total sample 0.03 (0.21, 0.16) 0.13 (0.003, 0.26)
Without ROA 0.03 (0.30, 0.36) 0.004 (0.18,0.19)
With ROA 0.04 (0.27, 0.19) 0.21 (0.04, 0.38)
Signiﬁcant differences are shown in bold.
Dependent variables: BMLs (yes vs no) for logistic regression or total bone marrow
lesions score for linear regression. Independent variables: SPFP mass effects or
signal intensity alteration (yes vs no).
* Adjusted for age, sex, BMI, diabetes, cardiovascular diseases, rheumatoid
arthritis and/or radiographic osteoarthritis.signal intensity alteration with JSN rather than cartilage defects or
volume. SPFP mass effect and signal intensity combined (any or
both) was signiﬁcantly associated with only tibial (medial and
lateral combined) cartilage defects. Furthermore, those with both
SPFP mass effect and signal intensity alteration had greater prev-
alence of ROA. These suggest that SPFP mass effect and signal in-
tensity alteration may be pathological changes associating with
knee cartilage loss at a later stage of OA.
Subchondral bone changes including osteophytes and BMLs are
important features of OA, and are consistently associated with knee
pain36 and cartilage loss35. While BMLs identiﬁed on MRI would
represent earlier pathologies such as edema, necrosis, ﬁbrosis and
inﬂammation in subchondral bone39, osteophytes seen on radio-
graphs denote abnormal bony outgrowth at a relatively later stage
of OA38. We found in this study that SPFP mass effect was not as
common as signal intensity alteration suggesting SPFP mass effect
may be a later-stage pathology than signal intensity alteration.
They wereweakly correlated with each other suggesting they could
reﬂect different pathophysiologies and have different natural his-
tories. Pathological changes at different stages may not co-exist,
and this may be why we found that SPFP mass effect was signiﬁ-
cantly associated with osteophytes but not with BMLs; and SPFP
signal intensity alteration was signiﬁcantly associated with BMLs
rather than osteophytes. The signiﬁcant associations between SPFP
signal intensity alteration and BMLs were observed in subjects with
ROA, not those without ROA. Due to the nature of its cross-sectional
design, the temporal relationship is unknown this time.
In the current study, we found that 53% of the participants had
medial compartment JSN, but only 7% of these participants had
osteophytes and only 24% had cartilage defects in the same
compartment. The reasons for these discrepancies were unknown.
Two experienced clinicians assessed knee radiographic changes
using OARSI atlas andwe reported a similar phenomena for JSN and
osteophytes (a higher prevalence of JSN) in a young cohort17. It is
unknown if OARSI atlas would underestimate the prevalence of
osteophytes and/or overestimate the prevalence of JSN. The atro-
phic phenotype of ROA (deﬁned as few, if any, osteophytes, with
severe joint space loss) may be higher in our sample than in Fra-
mingham cohort40 and further work is required to assess ROA
phenotypes in our cohort. The different deﬁnitions for the preva-
lence of JSN (1) and of cartilage defects (2) could explain the
discrepancy for JSN and cartilage defects, and alteration in
meniscusmay also in part contribute the higher prevalence of JSN41.
The main strength of this study is that we selected participants
randomly from the community with a large sample size and both
structural and symptomatic assessments. This study has several
limitations. First, as this was a population-based study, biopsy to
show histopathology of SPFP abnormalities was not possible.
Future studies using bioptic and imaging assessments are required
to establish the clinical relevance of SPFP signal intensity alteration
and mass effect. Second, as our study is of cross-sectional design,
the causal relationship needs to be conﬁrmed by future longitudi-
nal studies. Lastly, measurement error may inﬂuence results, but all
assessments were highly reproducible suggesting this is unlikely.
In summary, SPFP mass effect and/or signal intensity alterations
are signiﬁcantly associated with radiographic OA, BMLs and knee
pain, suggesting that SPFP abnormalities may be a part of whole-
organ disease in knee OA. Due to its descriptive nature, the ﬁnd-
ings from this study are exploratory and need to be conﬁrmed by
future longitudinal studies.
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